Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseIND Approval |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Nanjing Aoluo Biotechnology Co., Ltd.
0 Patents (Medical) associated with Nanjing Aoluo Biotechnology Co., Ltd.
100 Deals associated with Nanjing Aoluo Biotechnology Co., Ltd.
100 Translational Medicine associated with Nanjing Aoluo Biotechnology Co., Ltd.